Urological Cancers

NEW: Investigating Non-Visible Haematuria for Suspected Bladder Cancer (May 2026)

HIOW Consensus Statement for Locally Agreed Pathway for Investigating Non-Visible Haematuria for Suspected Bladder Cancer

Process Map

Key Messages – Bitesize Learning

Haematuria management in cases of suspected bladder or kidney cancer – GatewayC

Women with bladder cancer are more likely to experience late diagnosis – GatewayC

Local/National Webinars

LMC: A Focus on Urological Cancers (1 hour 23 mins)

Dr David Isaac and Dr Jenny Rattray discuss the evidence base and clinical consensus around PSA testing and use cases to illustrate how we can identify urological cancers earlier and improve outcomes for patients.

Early Detection of Prostate Cancer in Primary Care – Prostate Cancer UK Education (1 hour)

This webinar will equip primary care professionals with the knowledge and practical tools to identify men at higher risk of prostate cancer, understand the nuances of PSA testing, and navigate recent changes in diagnostic pathways. Emphasis will be placed on recognising and addressing health inequalities, particularly among Black men and other high-risk groups.

Modules

Urological cancers – GatewayC (1 hour CPD)

Prostate Cancer – GatewayC (1 hour CPD)

Podcasts

Prostate cancer – GatewayC

Haematuria – GatewayC

LMC Prostate Cancer Podcast – Dr Camilla Janssen talks with Dr Jenny Rattray, GP Retainer and GP advisor at Wessex Cancer Alliance. She has an interest in urological cancers and has just completed the Prostate Cancer UK Primary Care Programme.

Resources

Cancer Research UK – Prostate Cancer Recognition and Referral Guide

Cancer Research UK – Your guide to diagnosing bladder and kidney cancers earlier

Wessex Cancer Alliance – PSA Consensus Statement (for healthcare professionals)

Cancer Matters Wessex – PSA Testing for Prostate Cancer (information for patients)

Urology

Accessibility Toolbar